Literature DB >> 1730216

Changes of the human liver GM3 ganglioside molecular species during aging.

L Riboni1, D Acquotti, R Casellato, R Ghidoni, G Montagnolo, A Benevento, L Zecca, F Rubino, S Sonnino.   

Abstract

Sialosyl-lactosylceramide, GM3, is the major ganglioside of human liver, where it constitutes more than 90% of the total lipid-bound sialic acid. When analyzed by thin-layer chromatography, human liver GM3 migrates as two main spots. They are representative of ganglioside molecular species which differ in the acyl moiety. The faster running spot is mainly composed of molecular species with non-hydroxylated C22-C24 acyl chains; the other contains mainly molecular species bearing non-hydroxylated C16-C18 and alpha-hydroxylated C16-C24 acyl chains. In this study the content of the two GM3 molecular species groups was investigated in 31 subjects ranging from 19 to 85 years of age. By thin-layer chromatography we observed that the group of molecular species containing non-hydroxylated C22-C24 acyl chains, decreased linearly with subject age, while that of non-hydroxylated C16-C18 acyl chains and hydroxylated C16-C24 acyl chains increased linearly. Fast-atom-bombardment mass spectrometry performed on seven samples from subjects ranging from 21 to 78 years of age demonstrated that the age-dependent increase of the lower spot is caused by an increase in the hydroxylated fatty acid form of GM3, the content of non-hydroxylated C16-C18 fatty acid species remaining constant with age.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730216     DOI: 10.1111/j.1432-1033.1992.tb19834.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  A procedure for the preparation of GM3 ganglioside from GM1-lactone.

Authors:  L Mauri; R Casellato; G Kirschner; S Sonnino
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

Review 2.  Fatty acid 2-Hydroxylation in mammalian sphingolipid biology.

Authors:  Hiroko Hama
Journal:  Biochim Biophys Acta       Date:  2009-12-21

3.  Synthesis, NMR characterization and divergent biological actions of 2'-hydroxy-ceramide/dihydroceramide stereoisomers in MCF7 cells.

Authors:  Zdzislaw M Szulc; Aiping Bai; Jacek Bielawski; Nalini Mayroo; Doreen E Miller; Hanna Gracz; Yusuf A Hannun; Alicja Bielawska
Journal:  Bioorg Med Chem       Date:  2010-09-28       Impact factor: 3.641

4.  Direct interaction, instrumental for signaling processes, between LacCer and Lyn in the lipid rafts of neutrophil-like cells.

Authors:  Elena Chiricozzi; Maria Grazia Ciampa; Giuseppina Brasile; Federica Compostella; Alessandro Prinetti; Hitoshi Nakayama; Roudy C Ekyalongo; Kazuhisa Iwabuchi; Sandro Sonnino; Laura Mauri
Journal:  J Lipid Res       Date:  2014-11-23       Impact factor: 5.922

5.  Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).

Authors:  Roger Sandhoff; Konrad Sandhoff
Journal:  Adv Neurobiol       Date:  2023

6.  Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T schwannoma cells.

Authors:  Nathan L Alderson; Hiroko Hama
Journal:  J Lipid Res       Date:  2009-01-22       Impact factor: 5.922

7.  Elastin peptides signaling relies on neuraminidase-1-dependent lactosylceramide generation.

Authors:  Anthony Rusciani; Laurent Duca; Hervé Sartelet; Aurore Chatron-Colliet; Hélène Bobichon; Dominique Ploton; Richard Le Naour; Sébastien Blaise; Laurent Martiny; Laurent Debelle
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

Review 8.  Role of very long fatty acid-containing glycosphingolipids in membrane organization and cell signaling: the model of lactosylceramide in neutrophils.

Authors:  Sandro Sonnino; Alessandro Prinetti; Hitoshi Nakayama; Mitsuaki Yangida; Hideoki Ogawa; Kazuhisa Iwabuchi
Journal:  Glycoconj J       Date:  2008-11-18       Impact factor: 2.916

9.  Identification of Ganglioside GM3 Molecular Species in Human Serum Associated with Risk Factors of Metabolic Syndrome.

Authors:  Lucas Veillon; Shinji Go; Wakana Matsuyama; Akemi Suzuki; Mika Nagasaki; Yutaka Yatomi; Jin-Ichi Inokuchi
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.